SARS-CoV-2 and HIV-1 - a tale of two vaccines.
Publication
, Journal Article
Haynes, BF
Published in: Nat Rev Immunol
September 2021
The rapid development of COVID-19 vaccines and their deployment in less than a year is a scientific and medical triumph that has raised a key question. Why do we have several SARS-CoV-2 vaccines but do not have a single HIV-1 vaccine?
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Nat Rev Immunol
DOI
EISSN
1474-1741
Publication Date
September 2021
Volume
21
Issue
9
Start / End Page
543 / 544
Location
England
Related Subject Headings
- env Gene Products, Human Immunodeficiency Virus
- Virus Latency
- Spike Glycoprotein, Coronavirus
- SARS-CoV-2
- Receptors, Virus
- Protein Binding
- Immunology
- Humans
- HIV-1
- COVID-19 Vaccines
Citation
APA
Chicago
ICMJE
MLA
NLM
Haynes, B. F. (2021). SARS-CoV-2 and HIV-1 - a tale of two vaccines. Nat Rev Immunol, 21(9), 543–544. https://doi.org/10.1038/s41577-021-00589-w
Haynes, Barton F. “SARS-CoV-2 and HIV-1 - a tale of two vaccines.” Nat Rev Immunol 21, no. 9 (September 2021): 543–44. https://doi.org/10.1038/s41577-021-00589-w.
Haynes BF. SARS-CoV-2 and HIV-1 - a tale of two vaccines. Nat Rev Immunol. 2021 Sep;21(9):543–4.
Haynes, Barton F. “SARS-CoV-2 and HIV-1 - a tale of two vaccines.” Nat Rev Immunol, vol. 21, no. 9, Sept. 2021, pp. 543–44. Pubmed, doi:10.1038/s41577-021-00589-w.
Haynes BF. SARS-CoV-2 and HIV-1 - a tale of two vaccines. Nat Rev Immunol. 2021 Sep;21(9):543–544.
Published In
Nat Rev Immunol
DOI
EISSN
1474-1741
Publication Date
September 2021
Volume
21
Issue
9
Start / End Page
543 / 544
Location
England
Related Subject Headings
- env Gene Products, Human Immunodeficiency Virus
- Virus Latency
- Spike Glycoprotein, Coronavirus
- SARS-CoV-2
- Receptors, Virus
- Protein Binding
- Immunology
- Humans
- HIV-1
- COVID-19 Vaccines